ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1544

Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis

Matt Woo1, Nadil Zeiadin1, Hayley Yurgan2, Dean Tripp3 and Mala Joneja1, 1Medicine, Queen's University, Kingston, ON, Canada, 2Psychology, Queen's University, Kingston, ON, Canada, 3Psychology, Anaesthesiology, Urology, Queen's University, Kingston, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: depression, Disease Activity, psychosocial factors, resiliency and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis is a chronic, systemic, autoimmune disease affecting 0.5 – 1% of the adult population that leads to a progressive decline in functional status1. Psychological distress, including depression, is common among patients with rheumatoid arthritis and a predictor of functional outcome2. Resiliency, the presence of effective coping and adaptation when faced with loss, hardship or adversity has been shown to be a protective factor in chronic disease, including autoimmune disorders such as SLE3. In this study, we aimed to assess predictors of depressive symptoms in patients with rheumatoid arthritis.

Methods: Twenty-one patients with a diagnosis of rheumatoid arthritis from a single center in Kingston, Ontario were evaluated with a demographics questionnaire, a 9-item self-reported depression scale (Patient Health Questionnaire 9, PHQ-9), a 4-item resilience scale (Brief Resilience Coping Scale, BRCS), as well as a physician administered measure of objective disease activity (DAS-28). Multiple regression analysis was conducted to assess predictors of depressive symptoms.

Results:  The sample had low to moderate disease activity (M = 3.10, SD = 1.56). The mean PHQ-9 score was 4.09 (SD = 4.03) and the mean resilience score was 13.86 (SD = 4.07). Disease activity (β = .38) and resilience (β = -.47) were significant predictors of depressive symptoms, R2 = .73, adjusted R2 = .64, F(5, 15) = 8.20, p < .01. Disease activity is a positive predictor and resiliency is a negative predictor of depressive symptoms.

Conclusion:  Resilience had the greatest regression weight, implicating resilience as an important target for psychological intervention. Assessment of resilience in patients with rheumatoid arthritis may allow for the identification of patients at risk for psychosocial distress and allow for the implementation of targeted therapies to improve functional status.

References:

1Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984). Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum, 27, 864–872.

2Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: A systemic review and meta-analysis. Rheumatology, 52, 2136-2148.

3Pousa Fara DA, Revoredo LS, Vilar MJ, Chaves Maia (2014) Resilience and treatment adhesion in patients with systemic lupus erythematosus. The Open Rheumatology Journal, 8, 1-8.


Disclosure: M. Woo, None; N. Zeiadin, None; H. Yurgan, None; D. Tripp, None; M. Joneja, None.

To cite this abstract in AMA style:

Woo M, Zeiadin N, Yurgan H, Tripp D, Joneja M. Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/resiliency-as-a-predictor-of-depressive-symptoms-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/resiliency-as-a-predictor-of-depressive-symptoms-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology